Surf Bio
- Biotech or pharma, therapeutic R&D
Surf Bio’s SnapShot™ technology enables simple, at-home subcutaneous administration of high-dose mAbs and biologics using standard autoinjectors. Our proprietary polymer platform supports ultra-high concentrations of 600+ mg/mL, enabling longer dosing intervals and potential extension of exclusivity—all achieved using standard manufacturing techniques for streamlined scalability and tech transfer.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}